AI Future - Mercedes EQ, page-3

From the same report:https://www.mordorintelligence.com/industry-reports/neuromorphic-chip-market

"Companies, such as BrainChip Holdings Ltd, are forming multiple partnership activities to utilize neuromorphic chips in curbing the spread of COVID-19. In May 2021, BrainChip Holdings Ltd partnered with precision immunology company Biotome Pty Ltd to develop a fast, accurate COVID-19 antibody test. The companies will explore how the Akida neural processor could improve the accuracy and information quality of the antibody tests while Biotome is developing by providing advanced AI capacity at the point of care."

"Competitive LandscapeAs the market for neuromorphic chips is very niche and in the initial phase of development, the market has a presence of a few players, such as BrainChip Holdings Ltd, Intel Corporation, SynSense AG, etc. Top players are growing intensely in this consolidated market scenario through various market development strategies, such as collaboration, market expansion, product innovation, and R&D activities. Hence the market concentration is medium.April 2021 – Brainchip Research Institute in Perth has entered into a research collaboration with precision immunology company Biotome Pty Ltd. Biotome is developing highly accurate antibody tests for infections. Brainchip's Akida neuromorphic processor chip will be used to interpret sensor responses and find out which responses are the most representative for protective antibodies."

Major Players

1. BrainChip Holdings Ltd
2. Intel Corporation
3. General Vision Inc.
4. Nepes Corp
5. SynSense AG